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Abstract
Members of the Dobrava–Belgrade virus (DOBV) species are hantaviruses carried by different Apodemus mice as reservoir hosts and causing
haemorrhagic fever with renal syndrome (HFRS) in humans. In Central Europe, the Kurkino genotype of DOBV, associated with the striped
ﬁeld mouse, Apodemus agrarius, is prevalent. This paper presents the ﬁrst extensive study of the serological and molecular diagnostics,
epidemiology and clinics of DOBV-Kurkino infections in Central Europe. Serum samples from 570 German patients living in the habitat of
A. agrarius (north and northeast Germany) and exhibiting febrile disease, were analysed. All samples were tested by ELISA, subsets of
samples were also analysed by immunoblot, neutralization assay, and RT-PCR. A group of 86 individuals was conﬁrmed as DOBV-infected.
The virus neutralization assay allowed a reliable identiﬁcation of DOBV antibodies during both acute and convalescent phases of infection.
However, differentiation of relevant DOBV genotypes was not possible by neutralization test but required molecular analysis. Whereas
DOBV IgM antibodies tend to persist in the infected organism, RNAaemia seems to be short. Nucleotide sequences were ampliﬁed from
four patients, and their analysis demonstrated infection by DOBV-Kurkino. With respect to the initial results, the high degree of identity of
local patient-derived and A. agrarius-derived virus sequences may allow a closer allocation of the geographical place where the human
infection occurred. In contrast to moderate/severe HFRS caused by the DOBV genotypes Dobrava or Sochi, all available data showed a mild
clinical course of HFRS caused by DOBV-Kurkino infection without lethal outcomes.
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Introduction
Hantaviruses, members of Bunyaviridae family, are emerging
viruses that cause haemorrhagic fever with renal syndrome
(HFRS) in Asia and Europe and hantavirus cardiopulmonary
syndrome in the Americas [1–4]. In Europe, two main human
pathogenic hantaviruses circulate in rodent hosts, Puumala
virus (PUUV) and Dobrava–Belgrade virus (DOBV) [4,5].
Humans are ‘dead-end hosts’ after infection by virus-containing
aerosols. The clinical course of HFRS comprises usually about
ﬁve distinctive phases; febrile, hypotensive, oliguric, diuretic
and convalescent [1,4]. In Germany alone, a total of 7252
symptomatic, laboratory-conﬁrmed cases of HFRS were
reported from 2007 to 2012 (www3.rki.de/SurvStat/Query
Form.aspx), with increasing peak activities in the outbreak
years 2007 (1687 cases), 2010 (2016 cases) and 2012 (2824
cases). These large hantavirus outbreaks were caused by
PUUV infections [6] whereas the role of DOBV infections in
Germany is still unclear.
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ORIGINAL ARTICLE VIROLOGY
After the discovery of the ﬁrst virus, which became the
prototype strain of the DOBV species [7], members of DOBV
were detected in various Apodemus mouse species. According
to their molecular phylogeny and reservoir hosts, DOBV can
be subdivided now into at least three genotypes: (i) Kurkino
(formerly called DOBV-Aa) hosted by the striped ﬁeld mouse,
Apodemus agrarius; (ii) Dobrava (DOBV-Af) hosted by the
yellow-necked mouse, Apodemus ﬂavicollis; and (iii) Sochi
(DOBV-Ap) hosted by the Caucasus ﬁeld mouse, Apodemus
ponticus [8]. The fourth lineage, Saaremaa, which is not
conclusively associated with human disease, is currently
recognized by the International Committee on the Taxonomy
of Viruses as a separate species [8]). The three DOBV
genotypes, Kurkino, Dobrava and Sochi, share a high degree of
similarity at the amino acid level but differ in their virulence to
humans [8,9]. Case fatality rates range from 0.3–0.9% in
DOBV-Kurkino-infected patients [10,11] to more than 10% in
hospitalized patients infected with DOBV-Dobrava [12,13] or
DOBV-Sochi [10] (our unpublished results).
The ﬁrst two human DOBV infections in Germany were
serologically proven in 1998/99 [14,15] and molecular evidence
for infection of a patient with HFRS by DOBV-Aa (now named
Kurkino genotype) was reported in 2004 [16]. The natural host
of DOBV-Kurkino, A. agrarius, is present only in the northern
and northeastern parts of Germany (Fig. 1). Consequently,
DOBV-Kurkino was molecularly found in A. agrarius and in
spill-over infected A. ﬂavicollis animals in this geographical region
[17]. Moreover, a representative virus isolate was generated in
cell culture [18]. Sporadic cases of clinically apparent DOBV
infections are annually reported to the Robert Koch Institute as
the responsible federal agency in Germany and anecdotal cases
of mild [19] and even severe [20] clinical courses in
DOBV-infected patients have been described.
So far, comprehensive studies on molecular and serological
diagnostics, epidemiology and clinical characteristics of
DOBV-Kurkino infections exist only from European Russia
[10,11] but not from Central Europe. Therefore, we have
analysed hantavirus infections from Germany to clarify the
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FIG. 1. Residences of Dobrava–Belgrade virus (DOBV) -infected patients in Germany. The shaded area indicates the geographic distribution of
Apodemus agrarius according to www.european-mammals.org/. The numbers given in parentheses are the number of DOBV-seropositive patients
from these approximate geographical paces.
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extent of DOBV infections and to characterize the predom-
inant DOBV genotype.
Materials and Methods
Acute or post-acute phase sera from patients with putative
hantavirus infection were obtained from various clinics and
basic laboratories in northern and northeastern Germany with
the request of conﬁrmatory diagnostics (Fig. 1). Serological
diagnostics were based on ELISAs using hantavirus species-spe-
ciﬁc nucleocapsid proteins. IgM antibodies were detected in an
indirect assay format, whereas IgG was measured in a capture
assay. Sera were initially diluted 1 : 400, 1 : 1600 and
1 : 25 600. If necessary, end point titres were obtained by
geometrical serial dilution. Inconclusive ELISA results were
conﬁrmed by a commercial immunoblot assay (recomLine
Bunyavirus IgG/IgM; Mikrogen, Neuried, Germany). To further
characterize DOBV-positive samples, the chemilumines-
cence-focus reduction neutralizing test (c-FRNT) was applied
[21]. Reciprocal neutralizing titres of ≥ 1 : 40 were considered
as positive. The following virus strains were used for
neutralization assays; PUUV, strain Sotkamo [22]; DOBV-
Kurkino, strain Slovakia [23]; DOBV-Dobrava, strain Slovenia
[7]; and DOBV-Sochi, strain Ap1584 [10].
The molecular investigation of DOBV IgM-positive samples
was performed by a screening Pan-RT-PCR amplifying a
390-nucleotide-long region (positions 2947–3336, Accession
no.: JQ026206.1) of the L segment [24]. In cases of positive
outcome, an RT-PCR of a 317-nucleotide-long part (positions
1673–1989; JQ 26205) of the M segment [16] followed. PCR
products were sequenced bidirectionally (ABI Prism 310
Genetic Analyser; Life Technologies GmbH, Darmstadt, Ger-
many) using the ‘Big Dye RR Terminator Cycle Sequencing Kit’
(Applied Biosystems). The phylogenetic trees were constructed
with MEGA5 software (www.megasoftware.net/mega.php).
RNA from lung tissues originating from DOBV-infected
A. agrarius animals GER/08/118, GER/07/293 and GER/05/239
trapped in a previous study [17] was used for reverse
transcription-ampliﬁcation using the primers HanLF1 5′-ATG
TAYGTBAGTGCWGATGC and HanLR1 5′-AACCADTCW
GTYCCRTCATC and sequencing of the same L segment
regions as described above.
Results
Search for DOBV infections in north and northeast Germany
During the years 2007–2012, the National Consultation
Laboratory for hantavirus infections received serum samples
from 570 patients living in north or northeast Germany, the
natural habitat of A. agrarius. The majority of patients had fever
of unclear origin. The specimens were tested for hantavirus
antibodies using DOBV and PUUV nucleocapsid antigens; in
total, 93/570 (16.3%) were found to be seropositive.
On the basis of ELISA and—if results were not unequivocal—
immunoblot and c-FRNT data, seven of the 93 cases were
identiﬁed as PUUV infections (exhibiting strong cross-reactivity
to DOBV antigen in ELISA) and so were excluded from further
analysis. The remaining 86 patients were clearly identiﬁed as
being DOBV-infected. Sixteen of the 86 sera were exclusively
DOBV-reactive. Antibodies cross-reacting to PUUV antigen
were found in 65/86 samples, but with much lower titres than
DOBV antigen. Five samples revealed equal titres to both
antigens, but were unequivocally conﬁrmed as DOBV infection
by c-FRNT (data not shown). IgM antibodies in addition to IgG
class were detected in 61/86 (70.9%), indicating an acute or
post-acute infection. The remaining 25 sera were only IgG
positive, indicating either an early loss of IgM following the acute
phase of infection or a past hantavirus infection. The mean titre
for IgG as well as IgM was 1 : 6400 (data not shown).
Figure 1 shows a map of Germany, the geographic distri-
bution of A. agrarius, and the address of the DOBV-infected
patients. The mean age of the DOBV-seropositive patients was
42.9 years (range 11.7–81.4 years) and the male : female ratio
was 3.5 : 1.
Identiﬁcation of neutralizing antibodies in acute and
convalescent phase sera
In this study we have re-evaluated the suitability of the c-FRNT
for differentiation: (i) of infections by the virus species PUUV
versus DOBV and (ii) between infections by the three DOBV
genotypes, Kurkino, Dobrava and Sochi. Moreover, we wanted
(iii) to compare the suitability of sera from the acute versus
convalescent phases of disease to answer these questions.
Twelve of 86 sera from DOBV-infected individuals were
tested within the acute phase of the disease for the presence of
neutralizing antibodies (Table 1). The selection of these patients
was based on the availability of detailed patient records (e.g. data
of serum creatinine, platelet count, protein in urine). From 6/12
patients we obtained additional samples during the convalescent
phase (82–690 days after onset of symptoms).
As expected, neutralizing titres were found to be at least
four-fold higher against DOBV than against PUUV in all acute
phase sera. Examination of convalescent sera led to the same
outcome (Table 1).When taking a closer look at the anti-DOBV
titres, we found a slight decrease of neutralizing titres between
acute and convalescent sera (Table 1, patients 5, 6, 8–10).
The neutralization assay did not allow identiﬁcation of
the respective DOBV genotype involved in the patient’s
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infection with either acute or convalescent phase sera,. In
no case were neutralizing titres against one of the DOBV
genotypes four-fold higher than against the other two
genotypes.
Clinical ﬁndings in DOBV-infected patients
For 12 patients with DOBV infections, more detailed clinical
data were available. During the acute phase, nearly all of them
suffered from clinical signs compatible with a hantavirus
infection: fever >38.5°C as well as head, neck and abdominal
pain. The patients exhibited elevated serum creatinine, white
blood cells, liver enzymes (alanine aminotransferase and
aspartate aminotransferase), urea in serum and decreased
platelet counts in most cases. The clinical courses appeared to
be mild; oliguria and subsequent polyuria were reported for
only 4/12 patients and no patient died during the observation
period. Clinical characteristics and laboratory ﬁndings for this
group of patients are summarized in the Supporting informa-
tion (Tables S1A and B).
Molecular characterization of DOBV strains from patients
All 61 IgM-positive samples were screened by the Pan-RT-PCR
on the L segment. Of them, four patients were found to be
RNA-positive at the time of investigation. Two patients came
from urban villages near L€ubeck, State of Schleswig-Holstein
(H90 and H91), one patient from Neuruppin, State of
Brandenburg (H431) and one patient from Richtenberg, State
of Mecklenburg-Western Pomerania (H827). For the geo-
graphical location of these places, see Fig. 1.
Fig. 2(a) shows the results of the molecular phylogenetic
analysis of these four nucleotide sequences. All patient-derived
L segment sequences were found to cluster with the
DOBV-Kurkino genotype, represented by the local cell culture
virus isolate GRW GER/08/131 from Greifswald, which had
been completely sequenced [18]. Moreover, they were
compared with DOBV L sequences ampliﬁed from A. agrarius
animals, which were trapped in the vicinities of the living places
of patients H91 (Mu GER/08/118 Westergellersen), H827 (Mu
GER/08/131 DOBV Greifswald) and H431 (Mu GER/05/239
TABLE 1. ELISA and chemiluminescence-focus reduction neutralizing test titres (cFRNT) in serum samples of 12 patients during
the acute and convalescent phases of DOBV infection
Patient no.
Days after
onset of
symptoms
In-house ELISA (reciprocal titre) c-FRNT (reciprocal end-point titre)
DOBV-IgM DOBV-IgG PUUV DOBV-Kurkino DOBV-Dobrava DOBV-Sochi
Acute phase sera
1 A 3 6400 6400 40 320 160 160
2 A 4 400 ≥6400 40 1280 320 640
3 A 5 ≥6400 6400 40 640 320 640
4 A 11 25 600 6400 160 2560 1280 640
5 A 2 ≥6400 ≥6400 <40 5120 5120 320
6 A 13 6400 1600 <40 320 160 640
7 A 2 ≥25 600 6400 <40 320 320 40
8 A 5 ≥6400 6400 <40 320 160 80
9 A 2 102 400 25 600 40 320 640 320
10 A 2 6400 25 600 80 1280 1280 640
11 A 3 6400 1600 <40 320 320 160
12 A 1 25 600 6400 <40 320 160 160
Convalescent phase sera
5 B 172 <400 6400 < 40 1280 1280 320
6 B 528 <400 1600 < 40 160 160 80
8 B 455 25 600 6400 < 40 80 80 40
9 B 210 6400 25 600 < 40 320 160 160
10 B 82 1600 25 600 < 40 320 160 320
10 C 315 1600 ≥25 600 < 40 320 320 320
FIG. 2. Phylogenetic trees of human- and rodent-derived Dobrava–Belgrade virus (DOBV) sequences. Trees were constructed from a
389-nucleotide-long region of the L segment (a) or a 316-nucleotide-long region of the M segment (b) sequences with the MEGA5 software. The
evolutionary history was inferred by using the Maximum Likelihood method based on the Tamura three-parameter model and using a discrete c
distribution (+ G) with ﬁve rate categories and by assuming that a certain fraction of sites are evolutionarily invariable (+ I) which was estimated to
be the Best-Fit substitution model according to Bayesian Information Criteria. The scale bars indicate an evolutionary distance of 0.2 substitutions per
position in the sequence. Bootstrap values ≥ 70% (calculated from 1000 replicates) are shown at the tree branches. Sequences taken from GenBank
are indicated by their accession numbers. The human-derived sequences H90, H91, H431 and H827 (acc-no.s KF536031-5) and the rodent-derived
sequences Mu GER/07/293, Mu GER/08/118, and Mu GER/05/239 (acc-no.s KJ182937, KJ182938, and KJ425422) were obtained in this study. Human-
derived DOBV sequences are marked with a dot (●). The sequences of other Murinae-associated hantaviruses were used as outgroups: HTNV,
Hantaan virus; SANGV, Sangassou virus; SEOV, Seoul virus; THAIV, Thailand virus.
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Ostprignitz). These local rodent-derived sequences were
highly related to the respective patient-derived sequences. A
DOBV-positive A. agrarius animal from the residence of patient
H90 (Stockelsdorf) was not available.
An additional M segment sequence was obtained from
patient H431 (Neuruppin) and again, this sequence shared the
highest similarity with a rodent sequence (GER/05/477/
Ostprignitz) trapped at the same site (Fig. 2b).
All sequences belong to the DOBV-Kurkino genotype,
however, the clustering is not consistently well supported
(indicated by bootstrap values <70%), which might be a
consequence of the analysis of a short genomic fragment and
the still very limited sequence data set. It should also be noted
that in contrast to the S segment-based phylogenies, whichwere
used to deﬁne the genotypes (24), Saaremaa virus sequences
clustered together with Kurkino genotype sequences in the M
and L segment sequence-based phylogenetic analyses.
Discussion
This ﬁrst extensive study investigates DOBV infections in
Germany over a period of 6 years. Whereas the majority of
hantavirus disease cases in this country and, in particular, the
periodic outbreaks in west and south Germany, are caused by
PUUV infections [6], it seems that a lower number of cases
due to DOBV infection occurs in the natural habitat of the
striped ﬁeld mouse, A. agrarius. In our study, we found a
relatively constant distribution of the 86 DOBV-positive
patients over the years 2007–2012 (data not shown). Several
putative reasons might contribute to the imbalance between
the numbers of PUUV and DOBV infections: (i) less dense
population and lower reproduction rate of striped ﬁeld mice
compared with bank voles as PUUV host [25], (ii) low DOBV
seroprevalence rates in the A. agrarius population as described
recently for seven distinct trapping sites in the northern part of
Germany [17], (iii) limited public awareness of DOBV infec-
tions in north and northeast Germany, which might lead to
underestimation, and (iv) cross-reactivity between PUUV and
DOBV antibodies, which aggravates typing by routine ELISAs
[26]. The latter assumption is backed by seven nationwide
interlaboratory proﬁciency tests that clearly revealed a limited
detection speciﬁcity in the routine diagnostics of DOBV
infections (H. Zeichhardt, J. Hofmann, H.P. Grunert, D.H.
Kruger, unpublished data).
Applying our diagnostic algorithm of in-house ELISAs based
on yeast-expressed nucleocapsid protein and, if necessary,
immunoblot and c-FRNT, a total of 86 DOBV IgG-seropositive
patients was identiﬁed. Out of them, 61 patients were found to
also be IgM-positive. It seems that DOBV IgM antibodies tend
to persist. We have detected IgM antibodies with titres
between 1 : 1600 and 1 : 25 600 for up to 455 days after the
onset of clinical symptoms (Table 1, patients 8B–10C). More-
over, one patient (Table 1, patient 4B) had still detectable IgM
antibodies 690 days after onset, indicating that the production
of DOBV-speciﬁc IgM antibodies lasts longer than previously
thought. In another study, persisting IgM antibodies in a
time-frame of up to 100 days after DOBV infection have been
reported in 8/17 patients, in one patient an IgM titre of 1 : 400
(starting dilution) was detected even after 2 years [27].
The c-FRNT depicts a suitable tool for a ﬁnal decision DOBV
versus PUUV infection in the case of unresolved enzyme
immunoassay and immunoblot ﬁndings. Our data show that
DOBV-infected patients exhibit at least eight-fold higher neu-
tralizing antibody titres to this virus than to PUUV, independent
of the time of sample drawing after onset of disease. In
comparative neutralization assays of PUUV, Hantaan virus,
DOBV and Seoul virus, Lundkvist et al. [28] demonstrated the
occurrence of cross-reactive neutralizing antibodies during the
acute clinical phase andproposed theuseof convalescent sera for
serotyping. Interestingly, even in this study at least four-fold
neutralization titre differences for DOBV and PUUV were
achieved in 10/12 acute phase samples. In contrast to the clear
distinction between PUUV and DOBV infections, a differentia-
tion of the DOBV genotypes cannot be achieved by c-FRNT, in
neither acute nor convalescent phase samples. These data speak
for the serological relatedness of the genotypeswithin theDOBV
species, which usually does not result in reproducible four-fold
neutralizing titre differences when investigating the sera of
patients infected with a particular DOBV genotype [10,23].
Only molecular approaches provide a highly reliable classi-
ﬁcation of the DOBV genotypes. All three, S, L and M
segments, are used as targets for genotyping, but sometimes
with inconsistent results, due to possible genetic reassortment
events and the still limited number of M and L sequences
available in the databases. For more detailed molecular
epidemiological studies on DOBV, S-segment sequences are
the most suitable object [29]. Unfortunately, only one
patient-derived DOBV-Kurkino S-segment sequence was
obtained in Germany so far [16]. Out of the 61 IgM-positive
DOBV infections presented here, four patients were still
viraemic at the time of investigation. The generated sequences
of L-segment and M-segment origin demonstrate that
DOBV-Kurkino was the causative pathogen in these patients.
These data, together with the earlier ﬁnding of DOBV-Kurkino
S segment sequences in a patient [16] and in Apodemus mice
from northern Germany [17], support the classiﬁcation of the
Kurkino genotype as the German DOBV.
The obtained patient-derived and rodent-derived sequences
from the same geographical place were found to be closely
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related. This behaviour resembles recent ﬁndings about
locus-dependent clustering of patient-derived and rodent-der-
ived PUUV sequences in outbreak regions, which allow the
clear allocation of the geographical site of infection of each
patient [6].
It seems that the viral RNA in acutely DOBV-Kurki-
no-infected patients persists for a much shorter time than IgM
titres and, moreover, the RNA detection rate is lower
compared with those reported for humans infected by
DOBV-Dobrava [30]. It has been postulated that the viral
load in DOBV-Dobrava-infected patients correlates with the
degree of severity [31]. Whether, in turn, low viral loads and/
or shorter viraemic phases may be connected with signiﬁcantly
lower case fatality rates in DOBV-Kurkino-infected patients
has to be elucidated.
Despite single reports on moderate to severe clinical
courses due to DOBV infection in Germany [20], the patients
investigated here showed rather mild clinical symptoms. This is
reﬂected by lower values of serum creatinine, white blood
cells, alanine aminotransferase, aspartate aminotransferase,
urea in serum, and decreased platelet counts in patients
suffering from DOBV-Kurkino infection compared with
DOBV-Dobrava infection. Furthermore, the duration of
hospitalization (5.4 versus 28.5 days) and the proportion of
patients with indispensable haemodialysis (16.6 versus 45.5%)
emphasize the genotype-dependent severity of hantavirus
infections (see Supporting information, Table S1B). None of
our patients died, which is in agreement with the case fatality
rate of 0.3–0.9% as determined in larger clinical studies of
DOBV-Kurkino-infected patients in Russia [10,11]. It remains
to be elucidated why highly related DOBV genotypes such as
Kurkino, Dobrava and Sochi exhibit quite different virulence in
humans.
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